PEDIATRICS Vol. 104 No. 1 July 1999, pp. 79-86
Received Sep 2, 1998; accepted Feb 1, 1999.
,
,
From the Departments of * Pediatrics,
Radiology, and ** Family
Medicine and Clinical Epidemiology, University of Pittsburgh School of
Medicine and Children's Hospital of Pittsburgh, Pittsburgh,
Pennsylvania; the
Department of Pediatrics, Ohio State University,
and Columbus Children's Hospital, Columbus, Ohio; the § Department of
Pediatrics, Harvard School of Medicine, and Children's Hospital,
Boston, Massachusetts; the ¶ Department of Radiology (Nuclear
Medicine), George Washington University Medical Center, and Children's
National Medical Center, Washington, DC; and the # Pediatric
Kidney Center, Fairfax Hospital for Children, Fairfax, Virginia.
Background. The standard recommendation for treatment of young, febrile children with urinary tract infection has been hospitalization for intravenous antimicrobials. The availability of potent, oral, third-generation cephalosporins as well as interest in cost containment and avoidance of nosocomial risks prompted evaluation of the safety and efficacy of outpatient therapy.
Methods. In a multicenter, randomized clinical trial, we evaluated the efficacy of oral versus initial intravenous therapy in 306 children 1 to 24 months old with fever and urinary tract infection, in terms of short-term clinical outcomes (sterilization of the urine and defervescence) and long-term morbidity (incidence of reinfection and incidence and extent of renal scarring documented at 6 months by 99mTc-dimercaptosuccinic acid renal scans). Children received either oral cefixime for 14 days (double dose on day 1) or initial intravenous cefotaxime for 3 days followed by oral cefixime for 11 days.
Results. Treatment groups were comparable regarding demographic, clinical, and laboratory characteristics. Bacteremia was present in 3.4% of children treated orally and 5.3% of children treated intravenously. Of the short-term outcomes, 1) repeat urine cultures were sterile within 24 hours in all children, and 2) mean time to defervescence was 25 and 24 hours for children treated orally and intravenously, respectively. Of the long-term outcomes, 1) symptomatic reinfections occurred in 4.6% of children treated orally and 7.2% of children treated intravenously, 2) renal scarring at 6 months was noted in 9.8% children treated orally versus 7.2% of children treated intravenously, and 3) mean extent of scarring was ~8% in both treatment groups. Mean costs were at least twofold higher for children treated intravenously ($3577 vs $1473) compared with those treated orally.
Conclusions. Oral cefixime can be recommended as a safe and effective treatment for children with fever and urinary tract infection. Use of cefixime will result in substantial reductions of health care expenditures. Key words: urinary tract infection, acute pyelonephritis, therapy.
This article has been cited by other articles:
![]() |
I. K. Hewitt, P. Zucchetta, L. Rigon, F. Maschio, P. P. Molinari, L. Tomasi, A. Toffolo, L. Pavanello, C. Crivellaro, S. Bellato, et al. Early Treatment of Acute Pyelonephritis in Children Fails to Reduce Renal Scarring: Data From the Italian Renal Infection Study Trials Pediatrics, September 1, 2008; 122(3): 486 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Doganis and K. Sinaniotis Therapeutic Delay in Infant Urinary Tract Infection: Does It Really Have No Impact?: In Reply Pediatrics, July 1, 2008; 122(1): 216 - 216. [Full Text] [PDF] |
||||
![]() |
D. Doganis, K. Siafas, M. Mavrikou, G. Issaris, A. Martirosova, G. Perperidis, A. Konstantopoulos, and K. Sinaniotis Does Early Treatment of Urinary Tract Infection Prevent Renal Damage? Pediatrics, October 1, 2007; 120(4): e922 - e928. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Montini, A. Toffolo, P. Zucchetta, R. Dall'Amico, D. Gobber, A. Calderan, F. Maschio, L. Pavanello, P. P. Molinari, D. Scorrano, et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial BMJ, August 25, 2007; 335(7616): 386 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Garin and L. Young Much Pain, Little Gain From Voiding Cystourethrogram After Urinary Tract Infection Pediatrics, July 1, 2007; 120(1): 249 - 250. [Full Text] [PDF] |
||||
![]() |
T. B. Newman Much Pain, Little Gain From Voiding Cystourethrograms After Urinary Tract Infection Pediatrics, November 1, 2006; 118(5): 2251 - 2251. [Full Text] [PDF] |
||||
![]() |
S. Bonacorsi, V. Houdouin, P. Mariani-Kurkdjian, F. Mahjoub-Messai, and E. Bingen Comparative Prevalence of Virulence Factors in Escherichia coli Causing Urinary Tract Infection in Male Infants with and without Bacteremia. J. Clin. Microbiol., March 1, 2006; 44(3): 1156 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Friedman Rethinking UTI Prophylaxis AAP Grand Rounds, March 1, 2006; 15(3): 26 - 27. [Full Text] [PDF] |
||||
![]() |
E. H. Garin, F. Olavarria, V. G. Nieto, B. Valenciano, A. Campos, and L. Young Clinical Significance of Primary Vesicoureteral Reflux and Urinary Antibiotic Prophylaxis After Acute Pyelonephritis: A Multicenter, Randomized, Controlled Study Pediatrics, March 1, 2006; 117(3): 626 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wald Vesicoureteral Reflux: The Role of Antibiotic Prophylaxis Pediatrics, March 1, 2006; 117(3): 919 - 922. [Full Text] [PDF] |
||||
![]() |
C.-H. Cheng, Y.-K. Tsau, and T.-Y. Lin Effective Duration of Antimicrobial Therapy for the Treatment of Acute Lobar Nephronia Pediatrics, January 1, 2006; 117(1): e84 - e89. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lutter, M. L. Currie, L. B. Mitz, and L. A. Greenbaum Antibiotic Resistance Patterns in Children Hospitalized for Urinary Tract Infections Arch Pediatr Adolesc Med, October 1, 2005; 159(10): 924 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yared and K. M. Edwards Reevaluating Antibiotic Therapy for Urinary Tract Infections in Children Arch Pediatr Adolesc Med, October 1, 2005; 159(10): 992 - 993. [Full Text] [PDF] |
||||
![]() |
J. J. Zorc, D. A. Kiddoo, and K. N. Shaw Diagnosis and Management of Pediatric Urinary Tract Infections Clin. Microbiol. Rev., April 1, 2005; 18(2): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Van Howe A Cost-Utility Analysis of Neonatal Circumcision Med Decis Making, November 1, 2004; 24(6): 584 - 601. [Abstract] [PDF] |
||||
![]() |
D. T. Gray Neonatal Circumcision: Cost-Effective Preventive Measure or "the Unkindest Cut of All"? Med Decis Making, November 1, 2004; 24(6): 688 - 692. [PDF] |
||||
![]() |
M. Gauthier, I. Chevalier, A. Sterescu, S. Bergeron, S. Brunet, and D. Taddeo Treatment of Urinary Tract Infections Among Febrile Young Children With Daily Intravenous Antibiotic Therapy at a Day Treatment Center Pediatrics, October 1, 2004; 114(4): e469 - e476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Caviness, S. B. Cantor, C. H. Allen, and M. A. Ward A Cost-Effectiveness Analysis of Bacterial Endocarditis Prophylaxis for Febrile Children Who Have Cardiac Lesions and Undergo Urinary Catheterization in the Emergency Department Pediatrics, May 1, 2004; 113(5): 1291 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Lozano Treatment of acute pyelonephritis in children: Conclusions should have been more cautious BMJ, April 17, 2004; 328(7445): 957 - 957. [Full Text] |
||||
![]() |
J. C Craig and E. M Hodson Treatment of acute pyelonephritis in children BMJ, January 24, 2004; 328(7433): 179 - 180. [Full Text] [PDF] |
||||
![]() |
S. V. Gerasimov Probiotic Prophylaxis in Pediatric Recurrent Urinary Tract Infections Clinical Pediatrics, January 1, 2004; 43(1): 95 - 98. [PDF] |
||||
![]() |
M. L. Currie, L. Mitz, C. S. Raasch, and L. A. Greenbaum Follow-up Urine Cultures and Fever in Children With Urinary Tract Infection Arch Pediatr Adolesc Med, December 1, 2003; 157(12): 1237 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Galetto-Lacour, S. A. Zamora, and A. Gervaix Bedside Procalcitonin and C-Reactive Protein Tests in Children With Fever Without Localizing Signs of Infection Seen in a Referral Center Pediatrics, November 1, 2003; 112(5): 1054 - 1060. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shaikh, A. Hoberman, B. Wise, M. Kurs-Lasky, D. Kearney, S. Naylor, M. A. Haralam, D. K. Colborn, and S. G. Docimo Dysfunctional Elimination Syndrome: Is It Related to Urinary Tract Infection or Vesicoureteral Reflux Diagnosed Early in Life? Pediatrics, November 1, 2003; 112(5): 1134 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Prais, R Straussberg, Y Avitzur, M Nussinovitch, L Harel, and J Amir Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection Arch. Dis. Child., March 1, 2003; 88(3): 215 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoberman, M. Charron, R. W. Hickey, M. Baskin, D. H. Kearney, and E. R. Wald Imaging Studies after a First Febrile Urinary Tract Infection in Young Children N. Engl. J. Med., January 16, 2003; 348(3): 195 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Keren and E. Chan A Meta-analysis of Randomized, Controlled Trials Comparing Short- and Long-Course Antibiotic Therapy for Urinary Tract Infections in Children Pediatrics, May 1, 2002; 109(5): e70 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Piepsz Cortical scintigraphy and urinary tract infection in children Nephrol. Dial. Transplant., April 1, 2002; 17(4): 560 - 562. [Full Text] [PDF] |
||||
![]() |
K. B. Roberts Urinary Tract Infections in Young Febrile Infants: Is Selective Testing Acceptable? Arch Pediatr Adolesc Med, January 1, 2002; 156(1): 6 - 7. [Full Text] [PDF] |
||||
![]() |
K. Kassir, O. Vargas-Shiraishi, F. Zaldivar, M. Berman, J. Singh, and A. Arrieta Cytokine Profiles of Pediatric Patients Treated with Antibiotics for Pyelonephritis: Potential Therapeutic Impact Clin. Vaccine Immunol., November 1, 2001; 8(6): 1060 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. JANTUNEN, H. SAXEN, S. LUKINMAA, M. ALA-HOUHALA, and A. SIITONEN Genomic identity of pyelonephritogenic Escherichia coli isolated from blood, urine and faeces of children with urosepsis J. Med. Microbiol., July 1, 2001; 50(7): 650 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ladron de Guevara, P. Franken, C. De Sadeleer, H. Ham, and A. Piepsz Interobserver Reproducibility in Reporting on 99mTc-DMSA Scintigraphy for Detection of Late Renal Sequelae J. Nucl. Med., April 1, 2001; 42(4): 564 - 566. [Abstract] [Full Text] |
||||
![]() |
D Benador, T J Neuhaus, J-P Papazyan, U V Willi, I Engel-Bicik, D Nadal, D Slosman, B Mermillod, and E Girardin Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring Arch. Dis. Child., March 1, 2001; 84(3): 241 - 246. [Abstract] [Full Text] |
||||
![]() |
P. C. Baker, D. S. Nelson, and J. E. Schunk The Addition of Ceftriaxone to Oral Therapy Does Not Improve Outcome in Febrile Children With Urinary Tract Infections Arch Pediatr Adolesc Med, February 1, 2001; 155(2): 135 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hopp;, A. Hoberman, and E. R. Wald Intravenous Versus Oral Antibiotics for Urinary Tract Infections Pediatrics, October 1, 2000; 106(4): 865 - 865. [Full Text] |
||||
![]() |
Oral or IV Antibiotics for Febrile Children with Urinary Tract Infection? Journal Watch Infectious Diseases, October 1, 1999; 1999(1001): 14 - 14. [Full Text] |
||||
![]() |
K. B. Roberts A Synopsis of the American Academy of Pediatrics' Practice Parameter on the Diagnosis, Treatment, and Evaluation of the Initial Urinary Tract Infection in Febrile Infants and Young Children Pediatr. Rev., October 1, 1999; 20(10): 344 - 347. [Full Text] |
||||
![]() |
IV Antibiotics May Not Be Necessary for Children with UTIs Journal Watch Emergency Medicine, September 1, 1999; 1999(901): 13 - 13. [Full Text] |
||||
![]() |
Oral Antibiotics Effective Against Acute Pyelonephritis in Children Journal Watch (General), July 16, 1999; 1999(716): 4 - 4. [Full Text] |
||||
![]() |
M. C. Fisher Pyelonephritis at Home---Why Not? Pediatrics, July 1, 1999; 104(1): 109 - 111. [Full Text] |
||||
Read all P3Rs